{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/2839919"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "GTx, Inc., a Delaware corporation incorporated on September 24, 1997 and headquartered in Memphis, Tennessee, is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for prostate and breast cancer, cancer supportive care, including prevention and treatment of cancer-related muscle wasting or c" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "sec.gov" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/424608166"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/2839919" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/451450518"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/2839919"] } } }
